Results 121 to 130 of about 194,403 (293)
Heart failure in two male patients with late‐onset Fabry mutation (IVS4 + 919G > A)
ESC Heart Failure, Volume 12, Issue 2, Page 1508-1513, April 2025.
Xufei Yang +3 more
wiley +1 more source
Scientific Reports, 2017 The genetic background of dilated cardiomyopathy is highly heterogeneous, with close to 100 known genes and a number of candidates described to date.
Grażyna T. Truszkowska +10 more
doaj +1 more source
EPIDEMIOLOGICAL ASPECTS OF IDIOPATHIC DILATED CARDIOMYOPATHY
, 2003 Epidemiological aspects of idiopathic dilated ...
A. S. Sisakyan, M. A. Gurevich
core
Stem Cell Therapy for Pediatric Dilated Cardiomyopathy
, 2013 Dilated cardiomyopathy is a serious and life-threatening disorder in children. It is the most common form of pediatric cardiomyopathy. Therapy for this condition has varied little over the last several decades and mortality continues to be high ...
Selem, Sarah +2 more
core +1 more source
Ischemic and Non ischemic Dilated Cardiomyopathy.
, 2014 Dilated Cardiomyopathy is a high-incident disease, which diagnosis of and treatments are clinical priority. The aim of our study was to evaluate the diagnostic potential of cardiac magnetic resonance (CMR) imaging; echocardiography and the biochemical ...
MIDIRI, Massimo +5 more
core +1 more source
Genetic Biomarkers in the Risk Assessment of Sudden Cardiac Events: A Personalized Approach
iNew Medicine, EarlyView.Genetic insights into the risk assessment of sudden cardiac events. ABSTRACT Sudden cardiac events are the leading cause of death worldwide. Conventional risk stratification methods, which largely depend on clinical history, imaging, and electrocardiography, are usually inadequate for identifying high‐risk individuals, especially those without visible ...
Shrikant Verma +5 more
wiley +1 more source
Journal of Applied Toxicology, EarlyView.ABSTRACT One of the most serious complications associated with the use of the chemotherapeutic agent doxorubicin (DOX) is cardiomyopathy. Although cardioprotective drugs such as angiotensin receptor‐neprilysin inhibitors (ARNI) are used to prevent cardiomyopathy in DOX patients, no studies have reported the relationship between ARNI and endoplasmic ...
Mert Unvan +3 more
wiley +1 more source
Cell therapy in dilated cardiomyopathy: from animal models to clinical trials
Brazilian Journal of Medical and Biological Research, 2011 Dilated cardiomyopathy can be the end-stage form and common denominator of several cardiac disorders of known cause, such as hypertensive, ischemic, diabetic and Chagasic diseases.
C. del Corsso, A.C. Campos de Carvalho
doaj +2 more sources
Infantile dilated cardiomyopathy caused by RPL3L gene mutation: A case report
Journal of International Medical ResearchRibosomal protein L3-like gene mutations have been implicated in early-onset severe dilated cardiomyopathy (OMIM #115200). This report describes an infant with dilated cardiomyopathy resulting from RPL3L gene mutations. A 2-month-old girl was admitted in
Biwei Mai +5 more
doaj +1 more source
Kardiomiopatia rozstrzeniowa i przerostowa u płodu matki z cukrzycą ciężarnych - opis przypadku [PDF]
Pediatric Endocrinology, Diabetes and Metabolism, 2010 There is an increased risk of a hypertrophic cardiomyopathy and congenital heart defects among newborns of diabetic mothers. We report a case of hypertrophic cardiomyopathy preceded with dilated cardiomyopathy in a fetus of a diabetic mother.
Monika Kwiatek +5 more
doaj